Address
Form of workAboutIGM Biosciences, Inc.
IGM Biosciences (Nasdaq:IGMS) is a clinical-stage biotechnology company committed to developing and delivering a new class of medicines to treat patients with cancer, infectious diseases, and autoimmune and inflammatory diseases. The Company’s pipeline of clinical and preclinical assets is based on the IgM antibody, which has 10 binding sites compared to conventional IgG antibodies with only 2 binding sites. We have created a proprietary IgM antibody technology platform that we believe is particularly well suited for developing T cell engagers, receptor cross-linking agonists, targeted cytokines, and target neutralizers. The Company also has an exclusive worldwide collaboration agreement with Sanofi to create, develop, manufacture, and commercialize IgM antibody agonists against oncology and immunology, and inflammation targets. For more information, please visitwww.igmbio.com.
IgM Antibodies and Autoimmune and Inflammatory Diseases
Antibody treatments have revolutionized outcomes for patients with autoimmune and inflammatory diseases, and IgMs are the first antibody defense against a pathogen infection. We are committed to exploring how the unique structure and binding properties of our IgM platform can improve outcomes for patients with these serious conditions.
IgM Antibodies and Oncology
IGM Biosciences has a T cell engager program, a receptor cross-linking agonist program and a targeted cytokine program in clinical studies for the treatment of patients with solid tumors and hematological malignancies.
Job Summary
We are seeking a collaborative clinical scientist with experience in autoimmune disease programs to support IgM-based pipeline molecule clinical development, including early-phase studies in autoimmune/inflammatory diseases.
Responsibilities:- Participate in development and clinical trial teams as well as cross-functional groups
- Lead development of clinical trial protocols and protocol-related documents (e.g., ICF, CRF, amendments)
- Assist with strategic insights, literature research, regulatory filings, site and investigator relationships, study data tracking and analysis, preparation of presentations and publications
- 8+ years of clinical trial experience including in the autoimmune therapeutic area with a track record of engaging with clinicians and scientists
- Advanced scientific or clinical degree preferred (e.g., PhD, PharmD, MPH, MD, RN)
- In-depth understanding of drug development including early phase clinical trial experience and sound knowledge of medical aspects of relevant guidelines and regulations (e.g., GCP, ICH)
- Clinical research skills including data listing review, protocol authoring, and data analysis
- Able to travel (<20%)
One of our top priorities is to maintain the health and well-being of our employees and their families. To achieve this goal, we are offering robust and comprehensive benefits with a variety of options:
·Medical, dental, and vision insurance. The full premium amount for our employees and their dependents is currently
covered by IGM
·STD, LTD, Basic Life and AD&D Insurance, Supplemental Life and AD&D Insurance
·401(k) Plan
·120 hours of Paid Time Off, 5 sick days per year, 10 holidays
·Cell phone & internet subsidy
·Employee Referral Bonus Program
·Annual training budget for professional development
·Commuter Benefit
·Annual bonus program
·New hire stock options
IGM is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity or expression, national origin or ancestry, age, disability, marital status, and veteran status. All qualified applicants will receive consideration for employment.
